Abbott Laboratories (ABT) Shareholder's Equity Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.77% |
| Dec 31, 2025 | 13.82% |
| Sep 30, 2025 | 76.23% |
| Jun 30, 2025 | 13.56% |
| Mar 31, 2025 | 46.78% |
| Dec 31, 2024 | 15.15% |
| Sep 30, 2024 | 69.85% |
| Jun 30, 2024 | -63.79% |
| Mar 31, 2024 | 0.09% |
| Dec 31, 2023 | 14.93% |
| Sep 30, 2023 | -28.56% |
| Jun 30, 2023 | 31.47% |
| Mar 31, 2023 | -133.43% |
| Dec 31, 2022 | 0.60% |
| Sep 30, 2022 | -31.43% |
| Jun 30, 2022 | -267.65% |
| Mar 31, 2022 | 48.68% |
| Dec 31, 2021 | 15.22% |
| Sep 30, 2021 | 16.10% |
| Jun 30, 2021 | -3.00% |
| Mar 31, 2021 | -83.13% |
| Dec 31, 2020 | 1.41% |
| Sep 30, 2020 | -30.59% |
| Jun 30, 2020 | 55.34% |
| Mar 31, 2020 | -126.01% |
| Dec 31, 2019 | -10.87% |
| Sep 30, 2019 | -19.34% |
| Jun 30, 2019 | 1.19% |
| Mar 31, 2019 | 1.02% |
| Dec 31, 2018 | -140.83% |
| Sep 30, 2018 | -16.01% |
| Jun 30, 2018 | -19.55% |
| Mar 31, 2018 | -14.93% |
| Dec 31, 2017 | 44.45% |
| Sep 30, 2017 | -16.40% |
| Jun 30, 2017 | -77.88% |
| Mar 31, 2017 | -14.88% |
| Dec 31, 2016 | -143.98% |
| Sep 30, 2016 | -15.78% |
| Jun 30, 2016 | -16.77% |
| Mar 31, 2016 | -15.09% |
| Dec 31, 2015 | 24.12% |
| Sep 30, 2015 | -15.35% |
| Jun 30, 2015 | -16.90% |
| Dec 31, 2014 | -8.83% |
| Sep 30, 2014 | 1.42% |
| Jun 30, 2014 | 3.49% |